What are the common specifications and prices of avatrombopag?

Avatrombopag (Avatrombopag), also known as Avatrombopag or the trade name "Sucoxin", is an oral thrombopoietin receptor agonist, mainly used to treat patients with thrombocytopenia related to chronic liver disease and chronic immune thrombocytopenia (ITP). It stimulates megakaryocytes in the bone marrow and promotes platelet production, thereby reducing the risk of bleeding in patients undergoing invasive procedures or in daily life.

Currently in mainland China, avatrombopag has been officially approved for marketing and included in medical insurance, and its clinical use is relatively mature. There are two common specifications available on the market: 20mg10 tablets and 20mg15 tablets. Among them, the market price of the original drug in the format of 20mg10 tablets is more than 5,000 yuan, and the market price of 20mg15 tablets is around 7,000 to 8,000 yuan. It should be noted that these prices are the public selling prices before reimbursement. The prices may be significantly reduced after medical insurance. Patients can go to the local hospital pharmacy or medical insurance office for detailed consultation.

In addition to the domestic original drug, avatrombopag also has Lao and Bangladeshi generic versions on the market in overseas markets. These generic drugs are usually produced by large local pharmaceutical companies under strict drug quality standards. Their drug ingredients are basically the same as the original drugs, and their clinical effects are also comparable. According to the latest market information, the price of generic drugs in Laos and Bangladesh is affordable, usually only a few hundred yuan per box, which greatly reduces the financial burden on patients, especially for patients who require long-term or multiple treatments.

Overall, avatrombopag has high clinical value, especially for patients with thrombocytopenia caused by liver disease or ITP. When purchasing drugs in China, you can get larger financial subsidies through medical insurance reimbursement. For patients under financial pressure or not covered by medical insurance, you can also consider using overseas generic drugs with reliable quality under the guidance of a doctor to achieve a more flexible and sustainable treatment plan. No matter which source of medicine you choose, you should follow your doctor's instructions to ensure the safety and efficacy of the medicine.

Reference materials:https://go.drugbank.com/drugs/DB11995